SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-067359
Filing Date
2024-05-31
Accepted
2024-05-31 16:30:04
Documents
1
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3817
  Complete submission text file 0000950170-24-067359.txt   5677
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Reporting) CIK: 0001739614 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-42031 | Film No.: 241010200
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Issuer) CIK: 0002007919 (see all company filings)

IRS No.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)